Researchers identify a new class of drugs that offer a safer, more targeted treatment for leukemia patients.

New CRISPR technology puts diseased microglia back on track.

The experimental treatment is effective against all SARS-CoV-2 variants of concern and could be readily modified to target other RNA viruses.

As temperatures rise, so does the risk of serious illness. Here’s how to protect yourself and your loved ones.

How UC is addressing “the greatest environmental and equity challenge facing California today.”

Social media has strongest tie to conduct disorder.

The brain’s dopamine network activated by high doses of nicotine could be tweaked to help people kick the habit.

Faculty with the Depression Grand Challenge have created a system for managing mental health that they hope can be scaled and customized.

At White House event, Howard Gillman discusses challenges facing U.S. universities in wake of Roe v. Wade overturn.

Infectious disease doctors say most people who get infected do not require hospitalization and the chance of contracting it remains “very low.”

UC Davis animal behaviorist Emma Grigg shares the ways dogs can express themselves.

The new RNA-based method advances personalized medicine for improved patient care.